#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Ocular lymphoma Ectonucleotide pyrophosphatase/phosphodiesterase 1 deficiency Idiopathic intracranial hypertension Osteosarcoma Non-small cell lung cancer Anti-glomerular basement membrane disease Acute myeloid leukaemia refractory Mycobacterium abscessus infection Small cell lung cancer Duchenne muscular dystrophy gene carrier Alport's syndrome Glomerulonephritis minimal lesion Enteritis Chronic graft versus host disease in skin Granulomatosis with polyangiitis More trials…

    Learn about Rare Diseases

    IgA nephropathy – Trials in Disease Antisynthetase syndrome Pulmonary sarcoidosis – Trials in Disease Alport’s syndrome – Diagnostics Atypical haemolytic uraemic syndrome – Trials in Disease Breast angiosarcoma metastatic – Life with Disease CADASIL – Treatment Hypereosinophilic syndrome Gaucher’s disease type III – Life with Disease Myxofibrosarcoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Efmoroctocog Alfa Yttrium-90 Protrans Umeclidinium NIZUBAGLUSTAT Morphine Sulfate SONLICROMANOL HYDROCHLORIDE Rbl027.2 GXV813 Emavusertib Nido-361 Givinostat Skin Autograft Povidone Clenbuterol Hydrochloride Nemolizumab Io102 Hydrochloride Dexchlorpheniramine Utreloxastat Gsk4527226 More therapies…

    Learn about Your Condition

    Acromegaly Neuroendocrine carcinoma Infectious pleural effusion Brain neoplasm malignant Macular oedema Uveitis Coronary artery bypass Eclampsia Inflammation Pulmonary vascular disorder Abdominal wall pain H1N1 influenza Hepatitis D Ovarian epithelial cancer Cardiac valve disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Immune System Phenomena

  • Study on Tocilizumab and Prednisolone for Arthritis Caused by Cancer Immunotherapy in Cancer Patients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Eastern Cooperative Oncology Group performance status
    Investigated Drugs:
    • Prednisolone
    • Tocilizumab
    France Sweden

  • A study to evaluate the long-term safety and effectiveness of afimkibart in patients with atopic dermatitis who took part in previous afimkibart studies

    Recruiting

    2 1
    Investigated Drugs:
    • Ro7790121
    France Germany Italy Poland Spain

  • Efficacy and Safety of Berotralstat for Preventing Angioedema Attacks in Patients with Acquired Angioedema due to C1 Inhibitor Deficiency

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Berotralstat
    Italy

  • Testing Intralymphatic Allergen Immunotherapy for Teenagers and Adults with Grass Pollen Allergy Causing Hay Fever or Asthma

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Conjunctivitis allergic
    Italy

  • Efficacy and Safety Evaluation of Dazodalibep in Patients with Moderate-to-Severe Systemic Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study

    Not recruiting

    3 1
    Investigated Diseases:
    • Sjogren’s syndrome
    Investigated Drugs:
    • Dazodalibep
    Belgium Croatia Denmark France Germany Greece +6

  • Evaluation of Dazodalibep Efficacy and Safety in Patients with Moderate-to-Severe Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study

    Not recruiting

    3 1
    Investigated Diseases:
    • Sjogren’s syndrome
    Investigated Drugs:
    • Dazodalibep
    Belgium Croatia Denmark France Germany Greece +6
Previous Page
1 2 3 4
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!